Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.
Purpose To evaluate whether the volume of wash out rinse after povidone iodine (PI) application for intravitreal injections (IVI) affects patients' ocular surface irritation.
Methods This was a prospective, single-masked, randomized-controlled trial consisting of 142 subjects . A total of 51, 45, and 46 patients received 3-mL, 10-mL, and 15-mL of ocular rinse respectively. Reductions in the Ocular Surface Disease Index (OSDI) and the Standardized Patient Evaluation of Eye Dryness II (SPEED II) surveys, conducted before and at 24-72 hours post-injection, were analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 3-mL washout with saline based ocular rinse post injection | Experimental |
| |
| 10-mL washout with saline based ocular rinse post injection | Experimental |
| |
| 15-mL washout with saline based ocular rinse post injection | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| OSDI questionnaire | Other | Ocular Surface Disease Index |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ocular Surface Disease Index | Patient symptoms questionnaire, range 0-28, higher score is associated with worse outcome. | 24-72 hours after injection |
| Measure | Description | Time Frame |
|---|---|---|
| Standardized Patient Evaluation of Eye Dryness II | Patient symptoms questionnaire, range 0-48, higher score is associated with worse outcome. | 24-72 hours after injection |
Not provided
Inclusion Criteria:
choroidal neovascular membrane or cystoid macular edema requiring intravitreal injections for treatment.
Exclusion Criteria:
active ocular infection, eyelid trauma, graft versus host disease, thyroid eye disease, pregnancy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dean McGee Eye Institute | Oklahoma City | Oklahoma | 73104 | United States |
Depending on their required use of the data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008268 | Macular Degeneration |
| D008269 | Macular Edema |
| ID | Term |
|---|---|
| D012162 | Retinal Degeneration |
| D012164 | Retinal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| SPEEDII questionnaire | Other | Standardized Patient Evaluation of Eye Dryness II questionnaire |
|